| Dr Milad L Pooran, MD | |
|
11116 Medical Campus Rd, Hagerstown, MD 21742-6710 | |
| (330) 790-8000 | |
| Not Available |
| Full Name | Dr Milad L Pooran |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 11116 Medical Campus Rd, Hagerstown, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962465252 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Meritus Medical Center | Hagerstown, MD | Hospital |
| Howard University Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Howard University | 0941109565 | 136 |
| Anacostia Medical Associates | 8123257821 | 31 |
News Archive
Environmental Tectonics Corporation's Sterilization Systems Group (SSG), a division of ETC's Control Systems Group (CSG), today announced the award of two new contracts for large, industrial sized sterilization systems from previous customers. The combined contract values exceed $700,000.
Mpex Pharmaceuticals, Inc. today announced the presentation of data from its Phase 2b clinical trial with Aeroquin™ (a proprietary aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF) at the American Thoracic Society (ATS) Annual Meeting in New Orleans.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
When a woman receives a breast cancer diagnosis, she may have many questions about her immediate future – the stage of the disease, what treatment she'll receive, where it will happen.
› Verified 1 days ago
| Entity Name | Howard University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033163597 PECOS PAC ID: 0941109565 Enrollment ID: O20040102000561 |
News Archive
Environmental Tectonics Corporation's Sterilization Systems Group (SSG), a division of ETC's Control Systems Group (CSG), today announced the award of two new contracts for large, industrial sized sterilization systems from previous customers. The combined contract values exceed $700,000.
Mpex Pharmaceuticals, Inc. today announced the presentation of data from its Phase 2b clinical trial with Aeroquin™ (a proprietary aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF) at the American Thoracic Society (ATS) Annual Meeting in New Orleans.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
When a woman receives a breast cancer diagnosis, she may have many questions about her immediate future – the stage of the disease, what treatment she'll receive, where it will happen.
› Verified 1 days ago
| Entity Name | Hospitalist Medicine Physicians Of Maryland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992945471 PECOS PAC ID: 8729138003 Enrollment ID: O20090608000332 |
News Archive
Environmental Tectonics Corporation's Sterilization Systems Group (SSG), a division of ETC's Control Systems Group (CSG), today announced the award of two new contracts for large, industrial sized sterilization systems from previous customers. The combined contract values exceed $700,000.
Mpex Pharmaceuticals, Inc. today announced the presentation of data from its Phase 2b clinical trial with Aeroquin™ (a proprietary aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF) at the American Thoracic Society (ATS) Annual Meeting in New Orleans.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
When a woman receives a breast cancer diagnosis, she may have many questions about her immediate future – the stage of the disease, what treatment she'll receive, where it will happen.
› Verified 1 days ago
| Entity Name | Anacostia Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376973362 PECOS PAC ID: 8123257821 Enrollment ID: O20140129000331 |
News Archive
Environmental Tectonics Corporation's Sterilization Systems Group (SSG), a division of ETC's Control Systems Group (CSG), today announced the award of two new contracts for large, industrial sized sterilization systems from previous customers. The combined contract values exceed $700,000.
Mpex Pharmaceuticals, Inc. today announced the presentation of data from its Phase 2b clinical trial with Aeroquin™ (a proprietary aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF) at the American Thoracic Society (ATS) Annual Meeting in New Orleans.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
When a woman receives a breast cancer diagnosis, she may have many questions about her immediate future – the stage of the disease, what treatment she'll receive, where it will happen.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Milad L Pooran, MD 8408 Adler Ct, Millersville, MD 21108-1771 Ph: (202) 805-1822 | Dr Milad L Pooran, MD 11116 Medical Campus Rd, Hagerstown, MD 21742-6710 Ph: (330) 790-8000 |
News Archive
Environmental Tectonics Corporation's Sterilization Systems Group (SSG), a division of ETC's Control Systems Group (CSG), today announced the award of two new contracts for large, industrial sized sterilization systems from previous customers. The combined contract values exceed $700,000.
Mpex Pharmaceuticals, Inc. today announced the presentation of data from its Phase 2b clinical trial with Aeroquin™ (a proprietary aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF) at the American Thoracic Society (ATS) Annual Meeting in New Orleans.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
When a woman receives a breast cancer diagnosis, she may have many questions about her immediate future – the stage of the disease, what treatment she'll receive, where it will happen.
› Verified 1 days ago
Sadik Mohammed Ali, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 251 E Antietam St, Hagerstown, MD 21740 Phone: 301-790-8804 | |
Dr. Alida Mercedes Espinoza, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1130 Opal Ct, Hagerstown, MD 21740 Phone: 301-797-8279 Fax: 301-797-8504 | |
Dr. James E Cremins, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 11110 Medical Campus Rd, Suite 242, Hagerstown, MD 21742 Phone: 240-382-3783 Fax: 240-382-3799 | |
Jason Slack, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 11116 Medical Campus Rd, Hagerstown, MD 21742 Phone: 301-790-8804 | |
Fahad Lodhi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1733 Howell Rd, Hagerstown, MD 21740 Phone: 301-797-2525 | |
Dr. Tarek Nabil El-sherif, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 11110 Medical Campus Rd, # 223, Hagerstown, MD 21742 Phone: 301-560-4747 Fax: 301-776-1725 | |
Khetisuda Suvarnasuddhi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 12931 Oak Hill Ave, Hagerstown, MD 21742 Phone: 301-797-9600 Fax: 301-797-3854 |